Cardiovascular Risk And Prevention
Help Questions
USMLE Step 2 CK › Cardiovascular Risk And Prevention
A 61-year-old postmenopausal woman with type 2 diabetes presents for follow-up. She is adherent to metformin; A1c is 6.6%. She is sedentary and has BMI 29 kg/m². BP is 130/78 mm Hg. Lipids: LDL 116 mg/dL, HDL 45 mg/dL, triglycerides 165 mg/dL. She is not on lipid-lowering therapy. Family history includes mother with MI at 55. She asks which medication adjustment most reduces cardiovascular risk.
Which medication adjustment is most indicated based on the patient's profile?
Start moderate- to high-intensity statin therapy
Stop metformin to avoid hypoglycemia and reduce risk
Start aspirin daily regardless of bleeding risk
Start niacin as primary therapy to raise HDL
Start fenofibrate as first-line for LDL reduction
Explanation
This question tests cardiovascular risk and prevention for USMLE Step 2 CK, specifically understanding lipid management in diabetic patients with additional risk factors. Cardiovascular risk management involves evaluating ASCVD risk in diabetics, where guidelines recommend statin therapy for those aged 40-75 to reduce events, alongside lifestyle modifications. In the vignette, the patient's type 2 diabetes, postmenopausal status, family history of early MI, sedentary lifestyle, and elevated LDL indicate a high risk, warranting pharmacologic intervention despite controlled A1c and blood pressure. The correct answer, 'Start moderate- to high-intensity statin therapy,' is most indicated as it directly targets LDL reduction and is first-line for cardiovascular risk reduction in this profile per ACC/AHA guidelines. Choice B, starting fenofibrate, is incorrect because it is not primary for LDL management and is typically used for severe hypertriglyceridemia. To help students: Focus on memorizing statin indications in diabetes, including risk enhancers like family history, and avoid common pitfalls such as prioritizing therapies like niacin that have limited evidence. Practice integrating patient profiles with guidelines to select evidence-based adjustments over unnecessary changes like stopping effective medications.
A 58-year-old postmenopausal woman with type 2 diabetes mellitus presents for routine care. She takes metformin 1000 mg twice daily and reports excellent adherence; home glucose logs are generally 90–130 mg/dL. She is sedentary due to an office job and knee discomfort, and she eats most meals from takeout. She does not smoke and drinks wine socially. BP is 136/82 mm Hg; BMI 29 kg/m². Recent labs: A1c 6.6%, total cholesterol 212 mg/dL, LDL 128 mg/dL, HDL 44 mg/dL, triglycerides 180 mg/dL, creatinine 0.9 mg/dL, urine albumin/creatinine ratio 18 mg/g. She is not taking a statin because she “feels fine.” Family history includes her mother having a fatal MI at age 54 and a maternal uncle with coronary bypass surgery in his 50s. She asks which medication change best lowers her risk of heart attack and stroke.
Which medication adjustment is most indicated based on the patient's profile?
Stop metformin to reduce cardiovascular events
Add fenofibrate as first-line LDL lowering
Start moderate- to high-intensity statin therapy
Start daily aspirin regardless of bleeding risk
Begin niacin to raise HDL as primary therapy
Explanation
This question tests cardiovascular risk and prevention for USMLE Step 2 CK, specifically understanding risk assessment and preventive strategies in diabetic patients. Cardiovascular risk management involves assessing risk factors like diabetes, hypertension, dyslipidemia, and sedentary lifestyle, with preventive strategies prioritizing statin therapy for high-risk individuals. In the vignette, the patient's type 2 diabetes, elevated LDL, family history of premature CAD, and other risks warrant aggressive lipid management. The correct answer, 'Start moderate- to high-intensity statin therapy,' aligns with guidelines recommending statins for adults aged 40-75 with diabetes to reduce ASCVD events. Choice C, starting daily aspirin regardless of bleeding risk, is inappropriate as aspirin for primary prevention in diabetes is individualized and not automatic. To help students: Focus on ACC/AHA cholesterol guidelines for diabetics, differentiate primary vs. secondary prevention, and avoid overusing aspirin without risk-benefit assessment. Practice identifying statin intensity levels and indications.
A 28-year-old woman presents for a pre-employment physical. She has obesity (BMI 34 kg/m²) and smokes 8 cigarettes/day. She reports high job stress and sleeps 5 hours/night. BP is 142/90 mm Hg (repeat 140/88). Labs: total cholesterol 182 mg/dL, LDL 110 mg/dL, HDL 39 mg/dL, triglycerides 170 mg/dL, fasting glucose 99 mg/dL. She takes no medications. Family history: father had hypertension; no early CAD. She asks which recommendation would most reduce her cardiovascular risk.
What preventive measure should be prioritized for this patient?
Recommend smoking cessation with pharmacotherapy options
Order echocardiography to screen for LV hypertrophy
Increase dietary saturated fat to raise HDL
Start aspirin 81 mg daily for primary prevention
Start high-intensity statin therapy immediately
Explanation
This question tests cardiovascular risk and prevention for USMLE Step 2 CK, specifically understanding risk reduction in young adults. Cardiovascular risk management involves assessing smoking, obesity, and hypertension, with preventive strategies prioritizing cessation. In the vignette, the patient's smoking, obesity, stress, and BP elevate long-term risk. The correct answer, 'Recommend smoking cessation with pharmacotherapy options,' aligns with guidelines for comprehensive support to quit. Choice A, starting aspirin, is not indicated for primary prevention here. To help students: Discuss cessation pharmacotherapy, assess readiness to quit, and calculate lifetime vs. 10-year risk.
A 29-year-old man presents for an annual exam. He has obesity (BMI 35 kg/m²) and smokes 1 pack/day since age 19. He works a high-stress job with frequent late nights and eats mostly convenience foods. Over the past 6 months, workplace screenings show rising BP; today it is 146/92 mm Hg (repeat 144/90). He has no known chronic diseases and takes no medications. Labs: total cholesterol 198 mg/dL, LDL 122 mg/dL, HDL 36 mg/dL, triglycerides 190 mg/dL, fasting glucose 104 mg/dL. He is considering lifestyle changes but is unsure where to start. His father has hypertension; no known premature coronary disease. He asks what single change would most reduce his long-term cardiovascular risk.
What preventive measure should be prioritized for this patient?
Begin coronary CT angiography for risk stratification
Increase sodium intake to improve endurance
Start aspirin for primary prevention immediately
Start daily vitamin E supplementation
Recommend complete smoking cessation with support
Explanation
This question tests cardiovascular risk and prevention for USMLE Step 2 CK, specifically understanding modifiable risk factors in young adults. Cardiovascular risk management involves assessing factors like smoking, obesity, hypertension, and dyslipidemia, with preventive strategies emphasizing smoking cessation as a high-impact intervention. In the vignette, the patient's smoking history, obesity, elevated BP, and dyslipidemia significantly elevate long-term ASCVD risk. The correct answer, 'Recommend complete smoking cessation with support,' aligns with guidelines prioritizing smoking cessation to dramatically reduce CV events. Choice E, starting aspirin immediately, is not indicated for primary prevention in this low short-term risk young adult due to bleeding risks. To help students: Highlight the multiplicative effect of smoking on other risks, review cessation aids like varenicline or counseling, and understand when advanced imaging like CT angiography is unnecessary.
A 27-year-old man with obesity (BMI 33 kg/m²) and smoking presents for BP recheck. He smokes 15 cigarettes/day and reports high stress and minimal exercise. BP is 150/94 mm Hg. Labs: LDL 118 mg/dL, HDL 37 mg/dL, triglycerides 200 mg/dL, fasting glucose 102 mg/dL. He is not on medications. Family history is negative for early CAD. He asks whether vaping or “cutting down” is enough.
What preventive measure should be prioritized for this patient?
Recommend complete smoking cessation with counseling
Start aspirin to offset smoking-related risk
Increase saturated fat to raise HDL cholesterol
Order coronary calcium score before quitting
Switch to vaping as a safer long-term alternative
Explanation
This question tests cardiovascular risk and prevention for USMLE Step 2 CK, specifically understanding smoking cessation in young adults. Cardiovascular risk management involves addressing smoking as a top priority. In the vignette, the patient's smoking, obesity, hypertension, and lipids highlight cessation needs. The correct answer, 'Recommend complete smoking cessation with counseling,' aligns with guidelines over alternatives like vaping. Choice A, switching to vaping, is not safer long-term. To help students: Discuss cessation resources, assess dependence, and debunk reduced-harm myths.